ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

28 hedge funds and large institutions have $63M invested in Alpine Immune Sciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
6
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$810K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.78M
3
Victory Capital Management
3
Victory Capital Management
Texas
$578K
4
Deutsche Bank
4
Deutsche Bank
Germany
$301K
5
DS
5
DRW Securities
Illinois
$82K

Top Sellers

1
RSCM
1
Rock Springs Capital Management
Maryland
$0
2
OAM
2
Oxford Asset Management
United Kingdom
$0
3
Millennium Management
3
Millennium Management
New York
$110K
4
SIM
4
Spark Investment Management
New York
$108K
5
TRCT
5
Tower Research Capital (TRC)
New York
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$1K 96 -789 -89%
PWM
27
Perigon Wealth Management
California
$1K 150 – –
Barclays
28
Barclays
United Kingdom
$1K 134 +134 New
RSCM
29
Rock Springs Capital Management
Maryland
– – -150,000 Closed
OAM
30
Oxford Asset Management
United Kingdom
– – -11,919 Closed
Macquarie Group
31
Macquarie Group
Australia
– – -700 Closed
1
2